Mason Street Advisors LLC lifted its stake in Healthequity Inc (NASDAQ:HQY) by 1.5% in the first quarter, HoldingsChannel reports. The firm owned 28,864 shares of the company’s stock after acquiring an additional 433 shares during the quarter. Mason Street Advisors LLC’s holdings in Healthequity were worth $2,135,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Healthequity by 5.9% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,953 shares of the company’s stock worth $236,000 after purchasing an additional 220 shares in the last quarter. Global Retirement Partners LLC raised its position in Healthequity by 72.7% during the first quarter. Global Retirement Partners LLC now owns 556 shares of the company’s stock valued at $41,000 after acquiring an additional 234 shares in the last quarter. RMB Capital Management LLC raised its position in Healthequity by 0.5% during the fourth quarter. RMB Capital Management LLC now owns 50,933 shares of the company’s stock valued at $3,038,000 after acquiring an additional 252 shares in the last quarter. Crossmark Global Holdings Inc. raised its position in Healthequity by 6.6% during the fourth quarter. Crossmark Global Holdings Inc. now owns 5,140 shares of the company’s stock valued at $307,000 after acquiring an additional 320 shares in the last quarter. Finally, LPL Financial LLC raised its position in Healthequity by 2.4% during the fourth quarter. LPL Financial LLC now owns 17,177 shares of the company’s stock valued at $1,025,000 after acquiring an additional 409 shares in the last quarter. 96.76% of the stock is owned by institutional investors and hedge funds.
In other Healthequity news, VP Darcy G. Mott sold 4,000 shares of the stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $84.60, for a total transaction of $338,400.00. Following the transaction, the vice president now owns 70,000 shares in the company, valued at $5,922,000. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In the last quarter, insiders have sold 12,000 shares of company stock worth $876,200. Corporate insiders own 3.70% of the company’s stock.
Healthequity (NASDAQ:HQY) last announced its quarterly earnings results on Monday, March 18th. The company reported $0.21 EPS for the quarter, beating the consensus estimate of $0.15 by $0.06. Healthequity had a return on equity of 13.59% and a net margin of 25.73%. The company had revenue of $75.78 million for the quarter, compared to the consensus estimate of $74.28 million. During the same quarter last year, the company posted $0.09 earnings per share. The company’s revenue for the quarter was up 25.4% compared to the same quarter last year. Equities research analysts forecast that Healthequity Inc will post 0.94 EPS for the current year.
HQY has been the topic of several recent research reports. Chardan Capital reaffirmed a “buy” rating and set a $78.00 price objective (down previously from $82.00) on shares of Healthequity in a research report on Thursday, February 7th. SunTrust Banks raised shares of Healthequity from a “hold” rating to a “buy” rating and set a $81.00 price objective on the stock in a research report on Thursday, February 7th. BidaskClub lowered shares of Healthequity from a “strong-buy” rating to a “buy” rating in a research report on Saturday, March 30th. Zacks Investment Research raised shares of Healthequity from a “strong sell” rating to a “hold” rating in a research report on Tuesday. Finally, Bank of America reaffirmed a “neutral” rating and set a $82.00 price objective (up previously from $67.00) on shares of Healthequity in a research report on Friday, March 1st. Four investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. Healthequity currently has a consensus rating of “Buy” and a consensus price target of $88.33.
TRADEMARK VIOLATION WARNING: “Mason Street Advisors LLC Has $2.14 Million Holdings in Healthequity Inc (HQY)” was published by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this article on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The correct version of this article can be read at https://www.baseballdailydigest.com/news/2019/05/24/mason-street-advisors-llc-has-2-14-million-holdings-in-healthequity-inc-hqy.html.
Healthequity Company Profile
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthequity Inc (NASDAQ:HQY).
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.